JP2022505866A - 直交タンパク質ヘテロ二量体 - Google Patents
直交タンパク質ヘテロ二量体 Download PDFInfo
- Publication number
- JP2022505866A JP2022505866A JP2021522940A JP2021522940A JP2022505866A JP 2022505866 A JP2022505866 A JP 2022505866A JP 2021522940 A JP2021522940 A JP 2021522940A JP 2021522940 A JP2021522940 A JP 2021522940A JP 2022505866 A JP2022505866 A JP 2022505866A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- target
- domain
- monomer
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/002—Biomolecular computers, i.e. using biomolecules, proteins, cells
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03K—PULSE TECHNIQUE
- H03K19/00—Logic circuits, i.e. having at least two inputs acting on one output; Inverting circuits
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/10—Boolean models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/30—Dynamic-time models
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/914—Protein engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Mathematical Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Computing Systems (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Artificial Intelligence (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024107533A JP2024149492A (ja) | 2018-11-02 | 2024-07-03 | 直交タンパク質ヘテロ二量体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862755264P | 2018-11-02 | 2018-11-02 | |
| US62/755,264 | 2018-11-02 | ||
| US201962904800P | 2019-09-24 | 2019-09-24 | |
| US62/904,800 | 2019-09-24 | ||
| PCT/US2019/059654 WO2020093043A1 (en) | 2018-11-02 | 2019-11-04 | Orthogonal protein heterodimers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024107533A Division JP2024149492A (ja) | 2018-11-02 | 2024-07-03 | 直交タンパク質ヘテロ二量体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505866A true JP2022505866A (ja) | 2022-01-14 |
| JP2022505866A5 JP2022505866A5 (cg-RX-API-DMAC7.html) | 2022-11-11 |
Family
ID=68655751
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522940A Pending JP2022505866A (ja) | 2018-11-02 | 2019-11-04 | 直交タンパク質ヘテロ二量体 |
| JP2024107533A Pending JP2024149492A (ja) | 2018-11-02 | 2024-07-03 | 直交タンパク質ヘテロ二量体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024107533A Pending JP2024149492A (ja) | 2018-11-02 | 2024-07-03 | 直交タンパク質ヘテロ二量体 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US11820800B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3873919A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022505866A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210087959A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113272317A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019371462A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3117841A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020093043A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210087959A (ko) * | 2018-11-02 | 2021-07-13 | 유니버시티 오브 워싱톤 | 직교 단백질 이종이량체 |
| US20230399660A1 (en) * | 2020-10-23 | 2023-12-14 | Altius Institute For Biomedical Sciences | Cell Permeable Proteins for Genome Engineering |
| WO2022169913A2 (en) * | 2021-02-02 | 2022-08-11 | Outpace Bio, Inc. | Synthetic degrader system for targeted protein degradation |
| WO2023288190A1 (en) * | 2021-07-13 | 2023-01-19 | University Of Washington | Modular reconfigurable asymmetric protein assemblies |
| WO2023150649A2 (en) * | 2022-02-02 | 2023-08-10 | Outpace Bio, Inc. | Synthetic degrader system for targeted protein degradation |
| US20250136652A1 (en) * | 2022-03-02 | 2025-05-01 | The Regents Of The University Of California | Fusion protein for targeting recombinant proteins for degradation |
| WO2024026465A1 (en) * | 2022-07-29 | 2024-02-01 | The Broad Institute, Inc. | Programmable pattern recognition compositions |
| WO2026055533A1 (en) * | 2024-09-06 | 2026-03-12 | The Regents Of The University Of California | Synthetic receptors for engineered ligands |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11512620A (ja) * | 1995-10-06 | 1999-11-02 | ペンス | 発現されたタンパク質の検出および精製のためのコイルドコイルヘテロダイマー法および組成物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ507886A (en) * | 1998-05-19 | 2003-05-30 | Avidex Ltd | Multivalent T cell receptor complexes |
| WO2004007530A2 (en) * | 2002-07-17 | 2004-01-22 | The Center For Blood Research, Inc. | Modified proteins stabilized in a desired conformation and methods for producing same |
| DK1999154T3 (da) | 2006-03-24 | 2012-12-03 | Merck Patent Gmbh | Fremstillede heterodimere proteindomæner |
| US9217011B2 (en) * | 2007-09-07 | 2015-12-22 | Complix Nv | Non-natural proteinaceous scaffold made of three non-covalently associated peptides |
| US20110224404A1 (en) | 2010-03-11 | 2011-09-15 | Florida State University Research Foundation | Method for development of a peptide building block useful for de novo protein design |
| EP3436470A4 (en) | 2016-04-01 | 2019-11-20 | University of Washington | POLYPEPTIDES FOR THE PREPARATION OF HOMOOLIGOMERS WITH MODULAR HYDROGEN BONDING NETWORKED SPECIFICITY AND THEIR DESIGN |
| US20180068054A1 (en) * | 2016-09-06 | 2018-03-08 | University Of Washington | Hyperstable Constrained Peptides and Their Design |
| US10818377B2 (en) * | 2016-11-16 | 2020-10-27 | University Of Washington | Computational design of self-assembling cyclic protein homo-oligomers |
| US20210363214A1 (en) * | 2018-03-01 | 2021-11-25 | University Of Washington | Transmembrane polypeptides |
| CN112512544B (zh) * | 2018-07-19 | 2025-09-09 | 华盛顿大学 | 蛋白质开关的全新设计 |
| US20210324011A1 (en) * | 2018-10-25 | 2021-10-21 | University Of Washington | Self-assembling protein homo-polymers |
| KR20210087959A (ko) * | 2018-11-02 | 2021-07-13 | 유니버시티 오브 워싱톤 | 직교 단백질 이종이량체 |
| KR20210111761A (ko) * | 2018-12-04 | 2021-09-13 | 유니버시티 오브 워싱턴 | 단백질 기능 및 상호작용을 제어하기 위한 시약 및 방법 |
| US12583896B2 (en) * | 2019-01-07 | 2026-03-24 | The Regents Of The University Of California | Caged-degron-based molecular feedback circuits and methods of using the same |
| EP3908592A1 (en) * | 2019-01-07 | 2021-11-17 | University of Washington | De novo design of protein switches for tunable control of protein degradation |
| WO2020214549A1 (en) * | 2019-04-15 | 2020-10-22 | University Of Washington | Self-assembling 2d arrays with de novo protein building blocks |
| US20220144895A1 (en) * | 2019-04-18 | 2022-05-12 | University Of Washington | De novo design of tunable ph-driven conformational switches |
| WO2020257225A1 (en) * | 2019-06-17 | 2020-12-24 | University Of Washington | De novo design of phosphorylation inducible protein switches (phospho-switches) |
| WO2021158849A1 (en) * | 2020-02-07 | 2021-08-12 | University Of Washington | Multipartite and circularly permuted beta-barrel polypeptides and methods for their use |
-
2019
- 2019-11-04 KR KR1020217015999A patent/KR20210087959A/ko not_active Ceased
- 2019-11-04 US US17/285,033 patent/US11820800B2/en active Active
- 2019-11-04 EP EP19809338.7A patent/EP3873919A1/en not_active Withdrawn
- 2019-11-04 CN CN201980073145.5A patent/CN113272317A/zh active Pending
- 2019-11-04 JP JP2021522940A patent/JP2022505866A/ja active Pending
- 2019-11-04 CA CA3117841A patent/CA3117841A1/en active Pending
- 2019-11-04 AU AU2019371462A patent/AU2019371462A1/en not_active Abandoned
- 2019-11-04 WO PCT/US2019/059654 patent/WO2020093043A1/en not_active Ceased
-
2021
- 2021-09-23 US US17/482,713 patent/US20220017579A1/en not_active Abandoned
- 2021-10-15 US US17/502,485 patent/US20220098250A1/en not_active Abandoned
-
2023
- 2023-01-23 US US18/158,384 patent/US20240101615A1/en not_active Abandoned
-
2024
- 2024-07-03 JP JP2024107533A patent/JP2024149492A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11512620A (ja) * | 1995-10-06 | 1999-11-02 | ペンス | 発現されたタンパク質の検出および精製のためのコイルドコイルヘテロダイマー法および組成物 |
Non-Patent Citations (1)
| Title |
|---|
| J. MOL. BIOL., vol. Vol.428, p.385-398, JPN6023053954, 2016, ISSN: 0005403361 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220017579A1 (en) | 2022-01-20 |
| AU2019371462A1 (en) | 2021-05-20 |
| JP2024149492A (ja) | 2024-10-18 |
| WO2020093043A1 (en) | 2020-05-07 |
| CN113272317A (zh) | 2021-08-17 |
| US20220098250A1 (en) | 2022-03-31 |
| EP3873919A1 (en) | 2021-09-08 |
| US20210355175A1 (en) | 2021-11-18 |
| CA3117841A1 (en) | 2020-05-07 |
| KR20210087959A (ko) | 2021-07-13 |
| US11820800B2 (en) | 2023-11-21 |
| US20240101615A1 (en) | 2024-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240101615A1 (en) | Orthogonal protein heterodimers | |
| Tiede et al. | Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications | |
| Binz et al. | Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins | |
| Ebersbach et al. | Affilin–novel binding molecules based on human γ-B-crystallin, an all β-sheet protein | |
| Guellouz et al. | Selection of specific protein binders for pre-defined targets from an optimized library of artificial helicoidal repeat proteins (alphaRep) | |
| JP2004508033A (ja) | 反復モジュールを含む反復タンパク質の集合体 | |
| Rupert et al. | A new DNA-binding motif in the Skn-1 binding domain–DNA complex | |
| EP2161278B1 (en) | Single-chain coiled coil scaffold | |
| Patel et al. | Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS display | |
| Yasunaga et al. | Structurally similar but functionally diverse ZU5 domains in human erythrocyte ankyrin | |
| JP5904565B2 (ja) | 微小タンパク質の骨格構造に基づく分子ライブラリ | |
| Mason et al. | Role of hydrophobic and electrostatic interactions in coiled coil stability and specificity | |
| Markússon et al. | High-affinity anti-Arc nanobodies provide tools for structural and functional studies | |
| Lorenz et al. | The filamentous phages fd and IF1 use different mechanisms to infect Escherichia coli | |
| Manukian et al. | pH-dependent compaction of the intrinsically disordered poly-E motif in titin | |
| Meyer et al. | Insights into molecular interactions between the juxtamembrane and kinase subdomains of the Arabidopsis Crinkly-4 receptor-like kinase | |
| Xie et al. | Structural insights into the recognition of phosphorylated Hop1 by Mek1 | |
| Deng et al. | A heterospecific leucine zipper tetramer | |
| WO2023288190A1 (en) | Modular reconfigurable asymmetric protein assemblies | |
| Panigrahi et al. | The design and structure of outer membrane receptors from peroxisomes, mitochondria, and chloroplasts | |
| JP2009112282A (ja) | 極微小タンパク質およびその結晶 | |
| Wezner-Ptasińska et al. | Design and characteristics of a stable protein scaffold for specific binding based on variable lymphocyte receptor sequences | |
| Liu et al. | Synthesis, physicochemical characterization, and crystallization of a putative retro‐coiled coil | |
| Markússon et al. | High-affinity nanobodies as tools for structural and functional studies on mammalian Arc | |
| Nikolaev et al. | Rethinking Leucine Zipper–a ubiquitous signal transduction motif |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221102 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221102 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240105 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240401 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240828 |